Author

Joaquín Rullás

GlaxoSmithKline (Spain)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 1

Frequent Co-Authors

Alfonso Mendoza-LosanaiD· 2 shared David Barros-AguirreiD· 2 shared Rubén González del Río· 2 shared Adolfo García-Pérez· 1 shared Ángel Santos-Villarejo· 1 shared Charles J. ThompsoniD· 1 shared Eric L. NuermbergeriD· 1 shared Esther Pérez‐HerrániD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Alfonso Mendoza-LosanaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologyDrug Resistance UpdatesPeer-reviewedFeb 15, 2025

Sanfetrinem, an oral beta-lactam antibiotic repurposed for the treatment of tuberculosis

Santiago Ramón‐García, Rubén González del Río, María Pilar Arenaz-Callao…·Robert H. Bates

This paper identifies sanfetrinem cilexetil as a promising oral beta-lactam antibiotic for tuberculosis treatment through preclinical studies showing its activity against Mtb and potential for repurposing.

10 citationstop 3%

humanexperimental assay

𝕏 PostBluesky

Pharmacology & ToxicologyAntimicrobial Agents and ChemotherapyPeer-reviewedSep 30, 2024

Direct inhibitors of InhA with efficacy similar or superior to isoniazid in novel drug regimens for tuberculosis

Lourdes Encinas, Si‐Yang Li, Joaquín Rullás…·Eric L. Nuermberger

This study evaluates direct inhibitors of InhA (DIIs) for tuberculosis treatment, showing their efficacy comparable to isoniazid and their potential in new drug regimens.

9 citations

experimental assaydrug response / drug discovery

𝕏 PostBluesky